DFTXDefinium Therapeutics, Inc.

$38.21

What is the market doing?

What the tape says about DFTX

Definium Therapeutics, Inc. is +292% over the past year while the S&P 500 is +20%: 272 points ahead of the market.

+292%

1-year return · S&P 500 +20%

vs 200-day average
+67%

vs 200-day average · a clear uptrend

RSI (14)
23

RSI (14) · oversold, sold harder than it has been bought

Below its 52-week high
19%

Below its 52-week high

2024-08-15$4.89 – $47.08 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$38.21
1 monthS&P 500 −0.30%
−17%
1 yearS&P 500 +20%
+292%
5 yearsS&P 500 +85%
−16%
vs 50-day average$39.85
−4.1%
52-week high
$47.08
52-week low
$8.88
Annualised volatility
78%
Calendar-year price return
YearReturn
2026 (year to date)+185%
2025+92%
2024+90%
2023+66%
2022−89%
2021−55%
2020+5346%
2019+27%
2018−85%
2017−46%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan105 of 10+6.4%
Feb107 of 10+10.0%
Mar105 of 10+104%
Apr106 of 10+2.0%
May103 of 10−3.5%
Jun105 of 10−0.47%
Jul104 of 10−2.4%
Aug104 of 10+35%
Sep103 of 10−4.2%
Oct96 of 9+5.0%
Nov93 of 9+6.8%
Dec106 of 10+11%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.